NHS sets ambition to eliminate cervical cancer by 2040

The NHS has pledged to eliminate cervical cancer by 2040. Speaking at NHS Providers’ annual conference, NHS chief executive Amanda Pritchard outlined how the health service can achieve the goal by making it as easy as possible for people to get the lifesaving Human Papillomavirus (HPV) vaccination and increasing cervical screening uptake. England is among the first countries in the world to set this elimination ambition within the next two decades.

As part of new plans to put the NHS one step closer to eliminating the HPV virus, which causes up to 99% of cervical cancers, health and care professionals will be supported to identify those who most need the vaccine, through targeted outreach and offering jabs in more convenient settings.

The NHS will also set out plans to improve access to online vaccination appointments nationally, with millions more people able to view their full vaccination record and book vaccines on the NHS App over the coming months and years. The new measures will also give local health teams more flexibility to locate vaccine services in convenient local places such as libraries, community centres and local leisure or sport facilities. Vaccinations will become part of a ‘one-stop shop’, with NHS staff set to expand the offer of blood pressure tests and other health checks and advice, alongside routine vaccinations.

The HPV vaccine prevents invasive strains of the virus, known to cause almost all cervical cancers, as well as some mouth and throat cancers. It is given to both girls and boys in secondary school to protect them against catching the HPV infection and developing into pre-cancerous and cancer cells.

To eliminate cervical cancer by 2040, the NHS needs to ensure as many people as possible are being vaccinated against HPV, while also coming forward for cervical screening.

NHS screening helps prevent cervical cancer by using a highly effective test to check for high-risk HPV which may cause abnormal cells to develop in the cervix. These abnormal cells can, over time, turn into cancer if left untreated.

Alongside its vaccination drive, the NHS is inviting more people than ever before for cervical screening – over five million people aged 25 to 64 were invited last year, with 3.5 million tested – while self-sampling will be trialled to determine if it could be introduced as part of national screening.

Amanda Pritchard, chief executive of the NHS in England commented: “It is truly momentous to be able to set out such an important, life-saving ambition today – to eliminate cervical cancer would be an incredible achievement and through a combination of our HPV vaccination programme, and our highly-effective cervical screening programme, it could become a reality in in the next two decades.

“Vaccination and screening are the key tools which mean we are one step closer to achieving this and the NHS is already making it easier than ever before for people to protect themselves and their families – whether it’s through community outreach in areas of lower uptake or expanding the NHS app so that everyone has their vaccine history and booking options in the palm of their hand.

“As ever, the public can play their part by coming forward for their vaccines and screening appointments when invited – to achieve our goal of eliminating cervical cancer, we need as many people as possible to take up the offer."

 

Latest Issues

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

EBME Expo

Coventry Building Society Arena
26th - 27th June 2024

The AfPP Roadshow - Cardiff

TBA, Cardiff
13th July 2024

AfPP Annual Conference 2024

University of Warwick
2nd - 3rd August 2024

The Operating Theatres North Show 2024

Etihad Stadium, Manchester
12th September 2024

The AfPP Roadshow - London

Cavendish Conference Centre, London
14th September 2024